A Randomized Study of Patients with Advanced Gastric Adenocarcinoma Not Progressed After Six Cycles of XELOX (Capecitabine Plus Oxaliplatin) Followed by Capecitabine Maintenance or Clinical Observation
Research Square (Research Square)